Luciferase Reporter Cell Line - BEAS-2B

BEAS-2B is a widely used human bronchial epithelial cell line, originally derived from normal bronchial epithelium and immortalized, providing a stable in vitro model for airway biology research. Because bronchial epithelial cells form the first structural barrier against inhaled particulate matter, pathogens, allergens, cigarette smoke, environmental pollutants, and therapeutic aerosols, BEAS-2B cells are frequently used in respiratory system research, toxicological assessment, inflammation studies, and epithelial response analysis. The luciferase reporter gene cell line-BEAS-2B is an engineered derivative of the BEAS-2B cell line, stably incorporating the luciferase reporter gene system. Compared to transient transfection-based reporter gene assays, the stable luciferase reporter gene cell line-BEAS-2B offers higher reproducibility, lower experimental error, a simplified workflow, and is more suitable for repeated testing or medium- to high-throughput screening.

The luciferase reporter gene cell line-BEAS-2B can be widely used in respiratory, immunological, pharmacological, and toxicological research. One major application is the analysis of airway epithelial signaling pathways, such as inflammatory transcriptional responses induced by cytokines, microbial components, oxidative stress, smoke-related stimuli, particulate matter, or chemical irritants. By monitoring luciferase activity, researchers can rapidly assess whether test stimuli activate or inhibit target pathways in bronchial epithelial cells. This is particularly useful for studying the mechanisms related to asthma, chronic obstructive pulmonary disease, airway inflammation, viral infection responses, epithelial barrier dysfunction, and lung injury caused by environmental exposure. This cell line also has significant value for drug discovery and compound validation. Candidate anti-inflammatory drugs, pathway inhibitors, natural products, small molecules, biologics, or inhaled therapeutic agents can all be tested in human airway epithelial cells for their ability to regulate reporter gene activity. Due to the high sensitivity, strong quantification, and compatibility with multiwell plates, this system is well-suited for dose-response experiments, time-course studies, antagonist screening, and comparative evaluation of compound potency or toxicity.